- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about TAK
Recent news which mentions TAK
2 Best High-Yield Dividend Stocks to Buy Right Now
July 11, 2022
From Motley Fool
From Benzinga
From Motley Fool
Quant Ratings Updated on 66 Stocks
June 06, 2022
From InvestorPlace
From Motley Fool
From Benzinga
From Motley Fool
Takeda's Maribavir Reduces Hospitalization Rates, Hospital Stay In Post-Transplant Infection Patients
April 22, 2022
From Benzinga
From InvestorPlace
Why Nektar Therapeutics Stock Is Crashing Today
April 18, 2022
From Motley Fool
From Benzinga
Phathom Pharma's Vonoprazan Commercial Preparation Update At Needham Healthcare Conference
April 13, 2022
From Benzinga
From Benzinga
From Benzinga
Roche And AstraZeneca Settle Ultomiris Patent Lawsuit
February 22, 2022
From Benzinga
Takeda Inks $2B Gene Therapy Pact With Code Biotherapeutics
February 22, 2022
From Benzinga
From Benzinga
The Best Russell 2000 Stocks to Buy Before they Rebound
February 15, 2022
From InvestorPlace
Why Are Seagen Shares Sinking Today?
February 10, 2022
From Benzinga
Take a Leap Into Novavax Stock After Vaccine Sales Start
February 08, 2022
From InvestorPlace
From Benzinga
2 Dirt-Cheap Value Stocks to Buy Now
January 29, 2022
From Motley Fool
3 Healthcare Stocks With High Dividends
January 21, 2022
From Motley Fool
Worldwide Adoption of Novavax Vaccines Makes It a Winner
January 21, 2022
From InvestorPlace
Why Denali Therapeutics Stock Is Sinking This Week
January 13, 2022
From Motley Fool
Why Novavax Stock Is Jumping Today
December 28, 2021
From Motley Fool
FDA Rejects Takeda's Eosinophilic Esophagitis Candidate, Asks For Additional Study
December 22, 2021
From Benzinga
The Daily Biotech Pulse: Allakos Slips Negative Late-Stage Data, Pfizer & Merck Announce Fresh COVID Pill Deal With UK, Regulatory Setback For Takeda
December 22, 2021
From Benzinga
Why Novavax Stock Is Jumping Again Today
December 17, 2021
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.